Cargando…
BIMG-07. PHARMACOLOGICAL ASCORBATE ENHANCES RADIATION AND TEMOZOLOMIDE EFFECTIVENESS IN GLIOBLASTOMA BY A MECHANISM MEDIATED BY REDOX ACTIVE IRON
Pharmacological ascorbate (P-AscH(-); high dose intravenous infusions of vitamin C generating milli-molar plasma concentrations) has re-emerged as an anti-cancer therapy. Phase 1 clinical trials combining P-AscH(-) with chemotherapy and ionizing radiation demonstrate safety and promising clinical ou...
Autores principales: | Allen, Bryan, Petronek, Michael, Monga, Varun, Bodeker, Kellie, Smith, Brian, Buettner, Garry, Greenlee, Jeremy, Smith, Mark, Spitz, Douglas, Cullen, Joseph, Magnotta, Vincent, Buatti, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992261/ http://dx.doi.org/10.1093/noajnl/vdab024.006 |
Ejemplares similares
-
Magnetic resonance imaging (MRI) of pharmacological ascorbate-induced iron redox state as a biomarker in subjects undergoing radio-chemotherapy
por: Cushing, Cameron M., et al.
Publicado: (2020) -
Utilization of Pharmacological Ascorbate to Enhance Hydrogen Peroxide-Mediated Radiosensitivity in Cancer Therapy
por: Mehdi, Zain, et al.
Publicado: (2021) -
BIMG-17. EFFECTS OF THE TUMOUR MICROENVIRONMENT ON PROTOPORPHYRIN IX ACCUMULATION IN GLIOBLASTOMA
por: Walker, Paul, et al.
Publicado: (2021) -
Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer
por: Furqan, Muhammad, et al.
Publicado: (2022) -
BIMG-06. RESPONSE ASSESSMENT OF BEVACIZUMAB THERAPY FOR GLIOBLASTOMA BY USING MULTIPLE PET TRACERS
por: Miyake, Keisuke, et al.
Publicado: (2021)